Translate page

  • Presentations from the EHA2022 Congress

  • EHA 2022: Mechanisms of disease progression in chronic myeloid leukemia (S. Tiong Ong)

  • EHA 2022: Non-BCR-ABL1 biomarkers of prognosis in CML (Shady Awad)

  • COLT Meeting 2019: CML related topics

  • COLT Meeting 2019: The CML frontier

    Perspectives on the clinical aspects of the meeting from Professor Jorge Cortes
    MD Anderson Cancer Center
    University of Texas, Houston (USA)

    • Update on new studies including TIGER and SPIRIT II 
    • Long-term outcomes from clinical studies on treatment-discontinuation
    • Various aspects on treatment-free-remission such as predictors of success, biomarkers, gene analysis, use of digital PCR, pregnancy
    • New modalities and tools of monitoring patients 
    • Biology of CML and the role of microenvironment and molecular abnormalities

     {rscomments off}